NYSE:NTR - Nutrien Stock Price, Forecast & News

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien declared a quarterly dividend on Tuesday, July 30th. Shareholders of record on Monday, September 30th will be given a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 annualized dividend and a yield of 3.88%. The ex-dividend date is Friday, September 27th. This is a boost from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

Nutrien Ltd (NYSE:NTR) issued its earnings results on Monday, November, 4th. The company reported $0.24 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.36 by $0.12. The firm earned $4.13 billion during the quarter, compared to analyst estimates of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. Nutrien's revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.47 EPS. View Nutrien's Earnings History.

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

15 brokers have issued 12-month price targets for Nutrien's stock. Their forecasts range from $50.00 to $70.00. On average, they anticipate Nutrien's share price to reach $60.53 in the next year. This suggests a possible upside of 30.6% from the stock's current price. View Analyst Price Targets for Nutrien.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 3 hold ratings, 11 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Media coverage about NTR stock has been trending somewhat positive on Tuesday, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Nutrien earned a news impact score of 1.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Nutrien.

Nutrien saw a drop in short interest in October. As of October 31st, there was short interest totalling 3,960,000 shares, a drop of 17.7% from the September 30th total of 4,810,000 shares. Based on an average trading volume of 1,080,000 shares, the days-to-cover ratio is currently 3.7 days. Currently, 0.7% of the shares of the stock are short sold. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Mosaic (MOS), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), American Vanguard (AVD), CVR Partners (UAN), Calyxt (CLXT), Marrone Bio Innovations (MBII), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), China Green Agriculture (CGA), SenesTech (SNES) and Eden Research (EDEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), JPMorgan Chase & Co. (JPM), General Electric (GE), Micron Technology (MU), CVS Health (CVS), Verizon Communications (VZ), Cisco Systems (CSCO), Bank of America (BAC) and Wells Fargo & Co (WFC).

Nutrien's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Boston Partners (0.65%), Cambiar Investors LLC (0.48%) and Sumitomo Mitsui Trust Holdings Inc. (0.43%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Cambiar Investors LLC, Millennium Management LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc. and Russell Investments Group Ltd..

NTR stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Ilmarinen Mutual Pension Insurance Co, TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Parametric Portfolio Associates LLC and Man Group plc.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $46.36.

Nutrien has a market capitalization of $26.56 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]